Journal of Stroke & Cerebrovascular Diseases
Volume 19, Issue 4 , Pages 279-282, July 2010

Ischemia-modified Albumin and Heart Fatty Acid–binding Protein: Could Early Ischemic Cardiac Biomarkers Be Used in Acute Stroke Management?

  • Fanny Herisson, MD

      Affiliations

    • Department of Neurology and Stroke Unit, University Hospital, Nantes, France
    • Corresponding Author InformationAddress correspondence to Fanny Herisson, MD, Department of Neurology and Stroke Unit, Laennec Hospital, Boulevard Monod, FR-44093 Nantes Cedex, France.
    • ,
  • Odile Delaroche, MD

      Affiliations

    • Department of Biochemistry, University Hospital, Nantes, France
    • ,
  • Elisabeth Auffray-Calvier, MD

      Affiliations

    • Department of Neuroradiology, University Hospital, Nantes, France
    • ,
  • Benjamin Daumas Duport, MD

      Affiliations

    • Department of Neuroradiology, University Hospital, Nantes, France
    • ,
  • Benoit Guillon, MD

      Affiliations

    • Department of Neurology and Stroke Unit, University Hospital, Nantes, France

Received 6 April 2009; received in revised form 16 June 2009; accepted 1 July 2009. published online 17 May 2010.

Background

The detection of biomarkers such as ischemia-modified albumin (IMA) and heart fatty acid–binding protein (HFABP) is used in the early diagnosis of acute myocardial infarction. As these biomarkers are not organ specific, we tested them in the neurovascular field.

Methods

A total of 41 patients with acute stroke were enrolled (31 ischemic strokes and 10 intracerebral hemorrhages). IMA and HFABP levels were measured in serum samples collected within 4.5hours of stroke onset. Clinical, imaging, and outcome data were recorded.

Results

No difference in baseline IMA or HFABP was found between patients with ischemic and hemorrhagic stroke. There was no correlation among biomarker levels at admission, National Institutes of Health Stroke Scale score, or stroke volume. Neither of the biomarkers could predict short-term prognosis.

Conclusions

IMA and HFABP do not appear to be relevant in acute stroke management.

Key Words: Stroke, biomarkers, ischemia-modified albumin, heart fatty acid–binding protein

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1052-3057(09)00122-0

doi:10.1016/j.jstrokecerebrovasdis.2009.07.004

Journal of Stroke & Cerebrovascular Diseases
Volume 19, Issue 4 , Pages 279-282, July 2010

Article Tools

* Image Usage & Resolution